Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
10.9M
-
Number of holders
-
122
-
Total 13F shares, excl. options
-
8.24M
-
Shares change
-
-674K
-
Total reported value, excl. options
-
$111M
-
Value change
-
-$12.3M
-
Put/Call ratio
-
0.51
-
Number of buys
-
56
-
Number of sells
-
-64
-
Price
-
$13.48
Significant Holders of MEDIFAST INC - Common Stock, $0.001 par value per share (MED) as of Q1 2025
163 filings reported holding MED - MEDIFAST INC - Common Stock, $0.001 par value per share as of Q1 2025.
MEDIFAST INC - Common Stock, $0.001 par value per share (MED) has 122 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.24M shares
of 10.9M outstanding shares and own 75.52% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (950K shares), RENAISSANCE TECHNOLOGIES LLC (889K shares), VANGUARD GROUP INC (774K shares), ACADIAN ASSET MANAGEMENT LLC (386K shares), D. E. Shaw & Co., Inc. (333K shares), MORGAN STANLEY (294K shares), BANK OF AMERICA CORP /DE/ (289K shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (266K shares), GEODE CAPITAL MANAGEMENT, LLC (256K shares), and AMERICAN CENTURY COMPANIES INC (225K shares).
This table shows the top 122 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.